Zou et al. found that the number of lean NAFLD patients carrying rs738409 polymorphism in PNPLA3 was much greater than obese NAFLD and lean controls (Zou et al., 2020). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.